<DOC>
	<DOCNO>NCT01774877</DOCNO>
	<brief_summary>Bi Syndrome one Traditional Chinese Medicine（TCM）name , It mean obstruction Chinese , refer syndrome characterized obstruction qi blood meridian due invasion external pathogenic wind , cold dampness , manifest soreness , pain , numb , etc . Bi Syndrome contain Rheumatoid arthritis ( RA ) . RA chronic disease affect 20 million people world.It one common form autoimmune disease . Xin'an Medicine one Traditional Chinese Medicine originate AnHui . Xinfeng Capsule develop accord Xin'an medicine theory , long adopt treatment rheumatoid arthritis ( RA ) . The study aim evaluate effectiveness safety Xinfeng Capsule treatment RA .</brief_summary>
	<brief_title>A Clinical Study Xin'an Medicine Treatment Bi Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Leflunomide</mesh_term>
	<criteria>Diagnosis RA , classify American Rheumatism Association 1987 revise criterion . According Zheng diagnosis Traditional Chinese Medicine . age 18 65 year . For patient currently receive nonsteroidal antiinflammatory drug ( NSAIDs ) : Treatment stable dose last 4 week prior screening，or Patients take NSAIDs least 1 week prior screen . Patients take DMARDs least 4 week prior screen . Patients take corticosteroid ( ≤15mg prednisone Equivalent ) ≥4 week enter trial . Patients agree participate study sign inform consent form . Patients receive intraarticular systemic corticosteroid injection within 4 week screen . Patients high disease activity ( DAS283 score &gt; 5.1 ) . Patients diagnose chronic inflammatory disease connective tissue disease like sicca syndrome（SS） , systemic lupus erythematosus ( SLE ) etc ; Patients sever disease Cardiovascular , brain , lung , liver , kidney hematopoietic system ; Patients pregnant nursing mother Psychiatric patient . Patients active gastroduodenal ulcer gastritis cause longterm use NSAIDs ; The patient know hypersensitivity trial medicine . Patients participate clinical trial within 4 week screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>xinfeng capsule ;</keyword>
	<keyword>rheumatoid arthritis ( RA ) ;</keyword>
	<keyword>randomize ;</keyword>
	<keyword>double-blind ;</keyword>
</DOC>